Michihito Toda

Sarcopenia is a novel poor prognostic factor in male patients with pathological Stage I non-small cell lung cancer

Takuma Tsukioka, Noritoshi Nishiyama, Nobuhiro Izumi et al. · Japanese Journal of Clinical Oncology · 2017 · 74 citations

Pirfenidone suppresses polarization to M2 phenotype macrophages and the fibrogenic activity of rat lung fibroblasts

Michihito Toda, Shinjiro Mizuguchi, Yukiko Minamiyama et al. · Journal of Clinical Biochemistry and Nutrition · 2018 · 44 citations · Full text

Platelet‐to‐lymphocyte ratio predicts the prognosis of patients with non‐small cell lung cancer treated with surgery and postoperative adjuvant chemotherapy

Michihito Toda, Takuma Tsukioka, Nobuhiro Izumi et al. · Thoracic Cancer · 2017 · 36 citations · Full text

Carbon monoxide-releasing molecule, CORM-3, modulates alveolar macrophage M1/M2 phenotype in vitro

Hiroko Yamamoto-Oka, Shinjiro Mizuguchi, Michihito Toda et al. · Inflammopharmacology · 2017 · 24 citations

Inflammation, Translational Medicine, Inflammatory Lung Disease +9

Positive correlation between sarcopenia and elevation of neutrophil/lymphocyte ration in pathological stage IIIA (N2-positive) non-small cell lung cancer patients

Takuma Tsukioka, Nobuhiro Izumi, Shinjiro Mizuguchi et al. · General Thoracic and Cardiovascular Surgery · 2018 · 22 citations

Malignant Disease, Medicine, Immunology +9